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Abstract
Background: Circumstances surrounding injection initiation have not been well addressed in
many developing country contexts. This study aimed to identify demographic factors, sexual
behaviors and drug use characteristics related to injection initiation among drug users in northern
Thailand.
Methods: A cross-sectional survey was conducted among 2,231 drug users admitted to the
Northern Drug Treatment Center in Mae Rim, Chiang Mai, Thailand, between February 1, 1999
and December 31, 2000. A multiple logistic regression was employed to identify the independent
effects from potential risk factors of transition into injection.
Results: After controlling for other covariates, being 20 years of age or older, single, ever receiving
education, urban residence, and having a history of smoking or incarceration were significantly
associated with higher likelihood of injection initiation. Multiple sex partners and an experience of
sex abuse were associated with an increased risk of injection initiation. Comparing to those whose
first drug was opium, individuals using heroin as their initiation drug had greater risk of injection
initiation; conversely, those taking amphetamine as their first drug had less risk of injection
initiation. Age of drug initiation was negatively associated with the risk of injection initiation: the
older the age of drug initiation, the less the risk of injection initiation.
Conclusion: Injection initiation was related to several demographic factors, sexual behaviors and
drug use characteristics. Understanding these factors will benefit the design of approaches to
successfully prevent or delay transition into injection.
Background
A range of studies have examined the factors associated
with transition from non-injection into injection drug
use; however most of them are conducted in the devel-
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oped world [1-5]. This transition is a critical point in a
drug user's career for many reasons, particularly because it
is characterized by a heightened risk of acquiring HIV and
other blood-borne pathogens [6-8]. The process of initiat-
ing injection is complicated and informed by a myriad of
individual, social-culture, and environmental factors.
Demographic characteristics significantly associated with
transition into injection in developed countries have
included: being of younger age [5,9]; being female [10];
ethnic minority [3,11]; housing instability [5]; and being
a high school dropout [3]. Having a current steady sexual
relationship with a partner who is an IDU has long been
observed as a facilitating factor for transition into drug
injection [12]. Sexual abuse alone has put drug users at a
higher likelihood of injection initiation [5,13]. Many
studies have recorded the independent effect of drug use
characteristics on onset of injection, such as types of
recently used drugs [5,12]; intensiveness and/or length of
drug use [9-12,14,15]; and current treatment status [1]. At
the social-culture level, low socio-economic status has
consistently been found to be one of the most important
factors in initiating injection in the developed world [2,4].
An exploration of the circumstances around the critical
time of initiating injection practices in developing coun-
tries as related to medical outcomes has not been well
addressed. Limited evidence from China [16,17] indi-
cated that risk factors of injection initiation in developing
countries could be as similar as those in developed coun-
tries like younger age, ethnic minority and short duration
of heroin use. However, Lai et al [17] reported that being
male related to higher risk of injection initiation, which
has not been shown in other studies [10,18]. The situation
in Thailand is of particular interest because injecting drug
use continues to be a leading risk factor for HIV in the
country that was previously characterized as having a het-
erosexual epidemic [19]. After implementing the 100%
condom use program in the 1990s, by 2002 the national
HIV prevalence was about 2% and prevalence among 21
year-old military conscripts was under 1%, having
dropped from 4% in the mid-1990s [20]. Unfortunately,
similar prevention efforts have not been waged to reduce
HIV infection among injection drug users (IDUs), partly
due to lack of knowledge about injection initiation.
Drug use, especially use of methamphetamines, has
increased rapidly in recently years in Thailand, particu-
larly among young people [21-23]. Sattah and colleagues
[23] reported among adolescent students in northern
Thailand, 41.3% males and 19.0% females ever used
methamphetamines. The risk of HIV infection is high
among drug users in Thailand. The reported HIV inci-
dence was about 3%~19% [22,24,25]. As shown in other
places, IDUs had a much higher risk of HIV infection than
non-IDUs in northern Thailand [24-26]. Srirak et al. [21]
reported that among female drug users in northern Thai-
land the HIV prevalence among IDUs was six more times
than that among non-IDUs (25% vs. 4.1%). While it is
feasible to deliver harm reduction programs in Thailand
[27], they are currently very limited [26,28,29]
The purpose of this study was to identify demographic
and drug use factors related to onset of injection among
drug users, who were admitted to one large drug treatment
center, in order to provide information to develop harm
reduction strategies with the hope of preventing and con-
trolling drug injection as well as HIV infection.
Methods
Study population
This study was a part of a cohort study, the Opiate Users
Research (OUR) Study, which was initiated at the North-
ern Drug Treatment Center (NDTC), located in Mae Rim,
Chiang Mai Province, Thailand in 1999. NDTC is the larg-
est drug treatment center in northern Thailand. Between
February 1, 1999 and January 31, 2000 2,845 individuals
were admitted for inpatient treatment, which consisted of
21-day detoxification. OUR Study inclusion criteria were:
being 12 years or older; being admitted for opiate or
methamphetamine dependence; agreeing to receive pre-
and post-test HIV counseling and venipuncture for anti-
body testing for HIV infection; providing informed con-
sent for those 18 and older and parental consent and
assent for individuals below the age of 18; and comple-
tion of a behavioral questionnaire. Of 2,149 persons
determined to be eligible, 1,865 (87%) enrolled in this
study. An additional 366 IDUs admitted to NDTC
between February and December 2000 were also enrolled
in the study. A total of 2,231 drug users were therefore
included into this analysis. The study was approved by the
institutional review boards of the Royal Thai Ministry of
Public Health, Research Institute of Health Sciences, Chi-
ang Mai University and the Johns Hopkins University.
Data collection
The study questionnaire was developed based on infor-
mation from pilot studies (in-depth interviews and focus
groups) and a systematic literature review. A formal pre-
test was conducted in a similar setting. The questionnaire
has been translated into local languages and back-trans-
lated into English without information loss. Interviewers
received formal training and were fluent in 12 local lan-
guages. Study participants completed the interview in
their preferred language.
After explaining study requirements and obtaining
informed consent, an interviewer conducted a 30–40
minute risk factor questionnaire in a private setting. Fol-
lowing HIV pre-test counseling, a serum specimen was
collected; one week later patients were given their HIV testHarm Reduction Journal 2006, 3:10 http://www.harmreductionjournal.com/content/3/1/10
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results during HIV post-test counseling. The questionnaire
ascertained information on demographics, tobacco and
alcohol use, non-parenteral modes of HIV transmission,
and a comprehensive drug use and sexual behavior his-
tory. Drug use history included lifetime use of marijuana,
opium, heroin, methamphetamines, inhalants (paint
thinner and glue), sedatives and hypnotics, and other
drugs. Age at first use, priority of reasons for first use, and
use in the past year and in the past three months were
assessed for each drug. Route of drug administration
(inhalation, ingestion, and injection), frequency of use,
amount taken per dose, and purchase price of each drug
were assessed for all drugs used in the past 3 months.
Injection history was also obtained, including characteris-
tics of first injection, syringe sharing history, and syringe
disinfection practices. Drug treatment and family and
friends' drug use were also examined.
Dependent and independent variables
Independent variables included demographic factors, sex-
ual behaviors and drug use characteristics, specifically age,
gender, ethnicity, education, employment, residence,
number of sex partner, sex abuse history, types of drugs
ever used, and age of drug initiation. The dependent vari-
able was initiation of injection.
Statistical methods
Univariate analysis was conducted to describe the study
sample's demographics, sex and drug use behaviors. Con-
tinuous variables (age, number of lifetime sex partners
and age of drug initiation) were roughly categorized based
on their quartiles in the statistical analyses. Logistic regres-
sion was employed to assess both unadjusted and inde-
pendent effects of potential risk factors. Variables that
were included in the initial and final multiple logistic
models were based on statistical significance (p < 0.05)
and/or scientific importance. Interaction terms were sys-
tematically tested. A manual back-and-forth process was
employed to obtain the final parsimonious model. SAS
software (version 9.1, SAS Institute, Cary, North Carolina)
was used to conduct the analysis.
Results
Demographic factors, sexual behaviors and drug use 
characteristics
Descriptive results are located in Table 1. The median age
of this sample was 29.3 years with an inter-quartile range
(IQR) of 21.4~38.5 years. Nearly 90% of participants were
male and more than half (55.5%) were Thai, with the
remaining being ethnic minorities. In this analysis, the
marital statue of single (58.5%) included those who were
single, separated, divorced or widowed. Two-thirds of the
sample lived in rural areas. About one-third had no for-
mal education and only 16.6% completed 12 or more
years of education. Most of the participants were
employed (81.8%). Both smoking (93.0%) and drinking
(80.9%) were very common. About one-third of partici-
pants ever gave a history of incarceration. The HIV preva-
lence of this sample was 15.6%.
Half of the participants had five or more lifetime sex part-
ners with an IQR of 1~10. Forty participants (1.8%) ever
sold sex for money or drug and thirty one (1.4%) reported
they were sexually abused.
Opium (33.8%) was the most common initiation drug,
followed by marijuana (24.3%), amphetamine (21.4%)
and heroin (14.6%). The median age of drug initiation
was 17.3 years with an IQR of 15.1~22.7 years. In total,
879 participants (39.4%) ever injected drugs.
Correlates of injection initiation
Table 2 shows results from bivariate analysis. The unad-
justed odds ratio [UOR] indicated that older age (20 years
of age or over), male, Thai ethnicity and single civil status
were associated with a higher risk of injection initiation.
Drug users living in rural areas had less likelihood to ini-
Table 1: Demographic factors, sexual behaviors and drug use 
characteristics of 2,231 drug users admitted to NDTC, Chiang 
Mai, Thailand
Number (%) (n = 2231)
Age (years), Median (IQR) 29.3 (21.4~38.5)
Male 2005 (89.9)
Thai ethnicity 1238 (55.5)
Single* 1301 (58.3)
Rural residence 1685 (75.5)
Education
No schooling 725 (32.5)
≤ 6 years 500 (22.4)
7~11 years 635 (28.5)
12 or More years 371 (16.6)
Employed 1824 (81.8)
Ever smoking 2074 (93.0)
Ever drinking 1805 (80.9)
Ever been in jail/prison 732 (32.8)
HIV positive 347 (15.6)
Number of sex partners, median (IQR) 5.0 (1.0~10.0)
Ever selling sex 40 (1.8)
Ever sex abused 31 (1.4)
The first drug ever used
Opium 755 (33.8)
Heroin 326 (14.6)
Amphetamine 478 (21.4)
Marijuana 541 (24.3)
Others** 131 (5.9)
Age of drug initiation (years), median 
(IQR)
17.3 (15.1~22.7)
Ever injection 879 (39.4)
* Single includes single, separated, divorced, and widow
** Others include inhalants and tranquilizers/sedativesHarm Reduction Journal 2006, 3:10 http://www.harmreductionjournal.com/content/3/1/10
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tiate injection than those living in urban areas (UOR =
0.39). Comparing to those with no formal schooling, any
formal education increased the likelihood of injection ini-
tiation. A history of smoking, drinking or incarceration
related to higher risk of injection initiation. Multiple sex
partners and a history of selling sex or reporting sex abuse
were associated with increased likelihood of injection ini-
tiation. Comparing to opium users, using marijuana, her-
oin or other drugs had a higher risk of injection initiation
while using amphetamine as the initiation drug was asso-
ciated with a much lower risk. Comparing to drug users at
younger age (less than 16 years old), those at 16 to 18
years of age had a higher risk of injection initiation, while
those at 24 years of age or older had a lower risk.
Table 3 contains results from multiple logistic models
examining demographic, sexual, and drug use characteris-
tics associated with injection initiation. In the presence of
other variables, the demographics that were found signif-
icantly associated with initiation of injection were: being
20 years or older (Adjusted Odds Ratio [AOR] = 4.3 for
those 20~29 years old; AOR = 6.0 for those 30~39 years
old; and AOR = 5.3 for those 40 years of age or older);
being single, (AOR = 1.7); and being urban (change the
direction of the AOR). Those who had more education
(compared to those without schooling, AOR = 1.7 for
those with 6 or less years of education; AOR = 1.8 for
those with 7~11 years of eduction; and AOR = 12 or more
years of education), ever smoking (AOR = 2.9) or being
incarcerated (AOR = 5.0) all had an increased risk of start-
ing injection.
In terms of sex behaviors, more sex partners implied
higher risk of transition into injection (comparing to
those who did not have any or only one sex partner, AOR
= 1.5 for those with 6~10 partners; and AOR = 1.9 for
those with 11 or more partners). Having a history of sex
abuse was significantly associated with heightened risk of
starting injection (AOR = 3.3).
In terms of drug use, the type of initiation drug mattered:
comparing to opium users, heroin use was related to
higher likelihood of transition into injection (AOR = 2.7),
while amphetamine use was associated with a lower risk
of injection initiation (AOR = 0.098). Age of drug initia-
tion had a significant impact on the likelihood of starting
injection: compared to those who began drug use at less
than 16 years, the risk of initiating drug use at the age of
19~23 years old was about half (AOR = 0.56) as likely and
about one-quarter as likely (AOR = 0.25) for those initiat-
ing drug use at the age of 24 years or older.
Discussion
The study's findings indicate that demographic factors,
sexual behaviors and drug use characteristics account for
some of the risks in transition into injection. Drug users
who were older or single, obtained more education, lived
in urban areas, ever smoked or had an experience of incar-
ceration were more likely to initiate injection. Multiple
sex partners or a history of sex abuse related to a higher
likelihood of starting injection; using amphetamines
instead of heroin as the starting substance of abuse and
later drug initiation were associated with a lower risk of
injection initiation.
Contrary to a study conducted among street youths (14–
25 years of age) in Montreal, Canada [5], our data showed
that older age was associated with a higher risk of initia-
tion into injection. The obvious difference in study set-
tings and age structure between the two studies may
account for some of the difference in the age effects. Our
study participants were from a resource-limited country
and older than those in the Canada study. Furthermore,
all our participants were drug users, whose age was appar-
ently associated with both drug use history and mode of
drug administration. Old drug users might have involved
in the drug culture for an extended period of time. Thus,
it is not surprising that older drug users had great oppor-
tunity to transition into injection. In this analysis the
effect of drug use history was partly controlled by includ-
ing age of drug initiation into the final model; however,
the impact of initial and sequential drug use modes on
transition into injection was not extensively explored.
As a contextual factor, neighborhood (residence) has been
shown as an importance determinant of starting injection
[30]. Since most studies have been conducted in devel-
oped countries, the effect of rural residence on initiation
of injection is unknown. Our data demonstrated that peo-
ple living in rural areas had half the risk to initiate injec-
tion as those in urban areas after controlling for other
confounders such as education. Ethnicity and employ-
ment were initially included into the model but were
dropped due to statistical non-significance. In current
analysis, postal code was employed to define the types of
residence, and current residence was used as a surrogate
for the neighborhood that influenced the occurrence of
injection, which may have been inaccurate. If more
detailed information is available, it would be helpful to
explore how contextual factors influence and shape drug
users' behavior and injection practices in Thailand. As
Galea et al. [31] point out, to fully understand drug use
behaviors, researchers should address not only individual
risk behaviors but also contextual factors such as social
norms and neighborhood socioeconomic status by means
of statistical methods like multilevel analysis.
Not reported from some studies [5,32], we found multi-
ple sex partners (6 or more) to be a risk factor of transition
into injection. However, in line with other studies [5,13],Harm Reduction Journal 2006, 3:10 http://www.harmreductionjournal.com/content/3/1/10
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the experience of sexual abuse increased the likelihood of
injection initiation. Though not explored in this study,
others [33,34] have demonstrated that negative life events
and risky behaviors following sex abuse could be possible
mechanisms in the casual chain. In our study we cannot
determine the temporal relationships between sex behav-
iors and injection initiation, which makes it hard to estab-
lish the causal pathway.
Comparing to opium, taking heroin as the initiation drug
was associated with a larger likelihood of transition into
injection, while starting with amphetamines lowered the
risk. Mode of drug administration and multiple drug use
following initiation drug might account for their specific
effect. In the past three months, 72.9% of heroin users
injected the drug, while only 7.5% of amphetamine users
were injectors (data not shown). Furthermore, those start-
ing with amphetamines tended to stick with it; only
12.3% of them ever used heroin. Though behaviors in the
past three months were not necessarily constant over
time, they at least indicated some drug use pattern in our
sample. Among individuals starting from marijuana or
others (inhalants and tranquilizers/sedatives), 59.7% and
54.2% ever tried opium sometime late respectively, which
might partly explain the non-significant difference in risk
of injection between marijuana or others with opium.
Multiple drug use and the intensity of drug use were not
examined in the current analysis, though many other
studies [10,11,14] have indicted that they are related to a
higher risk of initiating injection.
In our study, younger age of drug initiation was signifi-
cantly associated with a higher risk of injection initiation
even after controlling for the effect of age and other demo-
graphics, which has not been reported in other studies
[5,32]. The interaction between age and age of drug initi-
ation was examined and the effect was not statistically sig-
nificant. As indicated by our results, those starting drug
use at less than 16 years had four times the risk of transi-
tion into injection than those starting at the age 24 years
or older. One implication for this finding is to focus
health education programs on youths.
The HIV prevalence at study enrollment among drug users
in our sample was 15.6%, which was comparable to the
results from other studies in similar settings [22,24,25].
Compared to the estimated HIV prevalence of 1~2%
among the adult population in Thailand [35], the risk of
HIV infection among drug users was clearly quite high.
Further analyses (data not shown) indicated that the risk
of HIV infection varied by age, age at drug initiation, injec-
tion status and types of recently used drugs. Drug users 20
years old or over had a higher prevalence of HIV infection
than those younger than 20 years old (18.4% vs. 3.7%, P
< 0.0001), while those starting drugs at younger age
(under 16 years old) had a higher risk of HIV infection
than those starting drug use at older ages (age of 16 years
old or over) (17.9% vs. 7.3%, P < 0.0001). Considering
the correlations between age, length of drug use (age of
drug initiation), and the accumulated risk of HIV infec-
tion during the entire course of drug use, the observed dif-
ferences in the risk of HIV infection between different age
groups and length of drug use were reasonable but unac-
ceptable. HIV prevention programs and health education
projects need to be enhanced and should target the popu-
lation at risk, especially youth. The HIV prevalence among
IDUs was 35.2% in our sample, which was 12.6 times
higher than that of non-IDUs (2.8%) (P < 0.0001). In
terms of drug use in the past 3 months, HIV prevalence
was highest among users of other drugs (inhalants and
tranquilizers/sedatives, 35.1%), followed by heroin users
(29.9%), amphetamine users (16.0%), marijuana users
Table 2: Unadjusted odds ratio for factors associated with 
initiation of injection
Unadjusted odds ratio (95% CI)
Age
Under 20 years old Reference
20~29 years old 8.3 (6.0~11.4)
30~39 years old 6.6 (4.8~9.2)
40 years old or older 3.2 (2.3~4.5)
Male 2.2 (1.6~3.1)
Thai ethnicity 1.4 (1.2~1.7)
Single 1.6 (1.3~1.9)
Rural residence 0.39 (0.32~0.47)
Education
No schooling Reference
≤ 6 years 2.5 (1.9~3.1)
7~11 years 1.4 (1.1~1.8)
12 or more years 2.5 (1.9~3.2)
Employed 0.96 (0.77~1.2)
Ever smoking 7.3 (4.2~12.7)
Ever drinking 2.1 (1.6~2.6)
Ever in jail 7.2 (5.9~8.7)
No. of lifetime sex partners
One or no partner Reference
2~5 partners 2.4 (1.9~3.1)
6~10 partners 3.9 (2.9~5.2)
11 or more partners 6.1 (4.7~7.9)
Ever selling sex 2.9 (1.5~5.6)
Ever sex abused 2.8 (1.4~6.0)
Type of initiation drug
Opium Reference
Marijuana 3.4 (2.7~4.2)
Heroin 3.4 (2.6~4.5)
Amphetamine 0.13 (0.085~0.20)
Others 3.9 (2.6~5.7)
Age of drug initiation
Under 16 years old Reference
16~18 years old 1.5 (1.2~1.8)
19~23 years old 1.0 (0.80~1.3)
24 years old or older 0.39 (0.30~0.50)Harm Reduction Journal 2006, 3:10 http://www.harmreductionjournal.com/content/3/1/10
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(15.0%) and opium users (10.4%). A study from the same
region [21] reported the HIV prevalence was 25% among
heroin injectors and 4.1% among opium or methamphet-
amine smokers. Gender could be one reason to the
observed difference in HIV risk since the sample for the
above study only included females. However, in our sam-
ple 44.2% of participants were multi-drug users. In the
past 3 months, 61.7 % of inhalants and tranquilizers/sed-
atives users, 46.4% of marijuana users, 40.8% of amphet-
amine users, and 21.9% opium users also reported using
heroin, which matched well with the observed HIV risk
for individual drugs. As shown in elsewhere [36], multiple
drug use was associated with a higher risk of HIV infec-
tion, especially when heroin injection was involved. This
finding indicates the importance of addressing the issue of
multiple drug use in harm reduction programs, and not
just focusing on injection of heroin or methampheta-
mines.
The interpretation of these results is subject to certain lim-
itations. One concern is the representativeness of the sam-
ple. Recruited from one large drug treatment center, drug
users in our study could be a highly selected group with
relatively high risks. Data have shown that a history of
drug treatment may reflect past severity of drug depend-
ence, itself a predictor of transition into injection [12,14].
Secondly, all behavioral data were from self-reports that
might be inaccurate. Nevertheless, all interviewers were
asked to evaluate the quality of the interview at the end of
each interview and most reported good cooperation and
judged the data to be moderately to very reliable. A study
by McElrath and colleagues [37] also showed that retro-
spective self-reports from injection drug users had good
reliability and consistency. The extent of under-reporting
of socially unacceptable activities or over-reporting was
unknown and inaccessible. Thirdly, some informative var-
iables such as types, modes, and intensiveness of drug use
prior to injection initiation were not assessed. Exploring
these risk factors could shed additional understanding of
the process of initiating injection, and might also benefit
the design of appropriate harm reduction program to tar-
get the individuals at risk. Finally, the cross-sectional
design of this study limited our ability to determine cau-
sality; some potential risk factors for transition into injec-
tion might result from the fact that the participant
initiated injection and then identified those experiences a
risk context, such as being in jail. Furthermore, the use of
a cross-sectional design could induce recall bias and sur-
vival bias.
Despite these limitations, we have identified several corre-
lates of injection initiation among drug users in this
Southeast Asian context. Understanding the factors
related to initiation into injection may be an important
tool in guiding how we modify current harm reduction
strategies or design new approaches to more specifically
target high-risk populations and high-risk behaviors to
delay or prevent the initiation of injection.
Conclusion
Injection initiation was related to several demographic
factors, sexual behaviors and drug use characteristics in
northern Thailand. The information from this study could
be employed to improve current efforts in harm reduction
in order to better serve the people at risk.
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Table 3: Adjusted odds ratio for factors associated with initiation 
of injection
Adjusted odds ratio (95% CI)
Age
Under 20 years old Reference
20~29 years old 4.3 (2.7~6.8)
30~39 years old 6.0 (3.6~10.2)
40 years old or older 5.3 (3.0~9.3)
Male
Thai ethnicity
Single 1.7 (1.3~2.2)
Rural residence 0.50 (0.37~0.66)
Education
No schooling Reference
≤ 6 years 1.7 (1.2~2.3)
7~11 years 1.8 (1.2~2.7)
12 or more years 1.5 (1.0~2.3)
Employed
Ever smoking 2.9(1.5~5.3)
Ever drinking
Ever in jail 5.0 (4.0~6.4)
No. of lifetime sex partners
One or no partner Reference
2~5 partners 1.1 (0.83~1.6)
6~10 partners 1.5 (1.0~2.2)
11 or more partners 1.9 (1.4~2.7)
Ever selling sex
Ever sex abused 3.3 (1.2~9.1)
Type of initiation drug
Opium Reference
Marijuana 0.98 (0.68~1.4)
Heroin 2.7 (1.9~3.8)
Amphetamine 0.098 (0.057~0.17)
Others 1.2 (0.70~2.1)
Age of drug initiation
Under 16 years old Reference
16~18 years old 0.83 (0.60~1.1)
19~23 years old 0.56 (0.39~0.79)
24 years old or older 0.25 (0.16~0.37)Harm Reduction Journal 2006, 3:10 http://www.harmreductionjournal.com/content/3/1/10
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